Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy Volunteers
Clinical trial NCT02771249 · COMPLETED
Trial details
- NCT number
- NCT02771249
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-03
- Primary completion
- 2021-08-17
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.